We lunched and learned, we watched webinars, we built partnerships, and best of all we got to talk to YOU. We learned about your sequencing challenges, celebrated your successes, and were humbled by the warm reception you gave Cloudbreak™ and AVITI™ FIT. As we bring the year to a close, let’s revisit the blog posts that resonated most with our community in 2023.
5. Bring your own cloud
You asked, we answered: Elembio™ Cloud delivers a much-requested feature that allows remote, real-time run monitoring. As the fifth-ranked post explains, Elembio Cloud features evergreen, ever-growing capabilities that simplify bioinformatics.
Introducing Elembio Cloud: Remote Run Monitoring and Simplified Cloud-Based Informatics
4. Methyl-Seq without the PhiX tax
Bisulfite samples typically require a sizable PhiX spike-in to increase diversity, making human health studies expensive. Enter avidity base chemistry (ABC), which maintains accuracy without diversity, so you waste fewer reads on PhiX while lowering per-run costs.
Tip: Our 16S amplicon sequencing solution also dodges the PhiX tax.
A New, Less Expensive Path to Methylation Detection in Place of Bisulfite Sequencing
3. Single cell is here to stay
Single cell is a star, notching the #3 spot and making a strong case for the ongoing appeal of this versatile sequencing technique. Many people were understandably curious about what Element brings to the single-cell space.
Single-Cell Sequencing and the Element AVITI System: A Perfect Pairing
2. Volume and the $200 genome
Savings proved a popular topic overall. Our silver-medal post clinches the trend with a walk-through of our $200 Genome program. Shawn Levy, PhD breaks down the pricing for multiple scenarios and explains in plain terms the benefits of this volume-based program.
How Element Got to the $200 Genome: Shawn Levy Explains
1. Agriculture hit big this year
Agriculture clinches the top spot with a post on low-pass whole-genome sequencing (WGS) and the future of genotyping. This year saw agriculture come to the forefront of genomics, perhaps due to the convergence of climate change and low-cost, end-to-end sequencing poised to replace microarrays—making 2023 a good time to assess options.
Low pass whole genome sequencing 101: AgBio and the future of genotyping
